詳細検索
2025/05/19 10:28 145.94 円 163.75 円 196.93 円 米国CAR-T細胞療法市場:製品別(Abecma(idecabtagene vicleucel)、Breyanzi(lisocabtagene maraleucel)、Carvykti(ciltacabtagene autoleucel)、Kymriah(tisagenlecleucel)、Tecartus(brexucabtagene autoleucel)、Yescarta (axicabtagene ciloleucel)、その他), 疾患別 (白血病、リンパ腫、多発性骨髄腫、その他), エンドユーザー別 (病院、がん治療センター), 地域別, 競争, 予測と機会, 2020-2030FUnited States CAR-T Cell Therapy Market, By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease (Leukemia, Lymphoma, Multiple Myeloma, Others), By End User (Hospitals, Cancer Treatment Centers), By Region, Competition, Forecast & Opportunities, 2020-2030F出版社:TechSci Research ![]()
ご購入・見積もりのご依頼、その他お問合せはデータリソースまでお気軽にどうぞ |